Business Context and Reporting Period
Company: ClearPoint Neuro, Inc. (formerly MRI Interventions, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: February 14, 2020
Reporting Period: The filing discloses a revenue outlook for the full year 2020.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that the Company issued a press release and investor presentation containing the 2020 revenue outlook, but the specific figures are located in the attached exhibits (Exhibit 99.1 and 99.2) rather than the body of this 8-K.
Material Changes
No material changes to financial results or operations are detailed in the text of this filing. The primary event reported is the issuance of updated forward-looking guidance for 2020.
Guidance, Outlook, and Management Commentary
- Revenue Outlook: On February 14, 2020, the Company issued a press release announcing its revenue outlook for 2020.
- Investor Presentation: An updated investor presentation was posted to the Company's website and is furnished as Exhibit 99.2. Management indicated this presentation may be used in conversations with analysts and investors.
- Legal Disclaimer: The information in Item 7.01 and the attached exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific 2020 revenue guidance figures.
- Review Exhibit 99.2 (Investor Presentation) for detailed operational context and assumptions supporting the outlook.
- Verify the Company's name change status from MRI Interventions, Inc. to ClearPoint Neuro, Inc.
- Confirm the trading symbol (CLPT) and exchange (Nasdaq Capital Market) for accurate market data retrieval.